REZOLUTE, INC. Amortization of Intangible Assets
REZOLUTE, INC. (RZLT) reported Amortization of Intangible Assets of $7.00 thousand for the 12-month period ending 2020-06-30, per its 10-K filed 2020-10-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2020-10-13
- REZOLUTE, INC. amortization of intangible assets for the quarter ending 2019-09-30 was $2.00K, a 0.00% change year-over-year.
- REZOLUTE, INC. amortization of intangible assets for the quarter ending 2018-12-31 was $1.65K, a 9.71% decline year-over-year.
- REZOLUTE, INC. amortization of intangible assets for the quarter ending 2018-09-30 was $2.00K, a 9.71% increase year-over-year.
- REZOLUTE, INC. amortization of intangible assets for the quarter ending 2018-06-30 was $1.53K, a 16.02% decline year-over-year.
- REZOLUTE, INC. amortization of intangible assets for fiscal 2020 was $7.00K, a 0.00% change from fiscal 2019.
- REZOLUTE, INC. amortization of intangible assets for fiscal 2019 was $7.00K, a 0.00% change from fiscal 2018.
- REZOLUTE, INC. amortization of intangible assets for fiscal 2018 was $7.00K, a 4.00% decline from fiscal 2017.
- REZOLUTE, INC. amortization of intangible assets for fiscal 2017 was $7.29K, a 0.00% change from fiscal 2016.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed | Amortization of Intangible Assets 39 month | Amortization of Intangible Assets 42 month | Amortization of Intangible Assets 45 month | Amortization of Intangible Assets 48 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | $7.00K 10-K · filed 2020-10-13 | |||||||||
| 2019-09-30 | $2.00K 10-Q · filed 2019-11-14 | |||||||||
| 2019-06-30 | $7.00K 10-K · filed 2020-10-13 | |||||||||
| 2018-12-31 | $1.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | $3.65K 10-Q · filed 2019-02-14 | $5.18K derived: sum of 3 quarters · filed 2019-11-14 | $7.00K derived: sum of 4 quarters · filed 2019-11-14 | ||||||
| 2018-09-30 | $2.00K 10-Q · filed 2019-11-14 | $1.82K 10-Q · filed 2018-12-14 | $3.53K derived: sum of 2 quarters · filed 2019-11-14 | $5.35K derived: sum of 3 quarters · filed 2019-11-14 | $7.18K derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | $1.53K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-10 | $3.35K derived: sum of 2 quarters · filed 2019-09-10 | $5.18K derived: sum of 3 quarters · filed 2019-09-10 | $7.00K 10-K · filed 2019-09-10 | $7.29K 10-K · filed 2018-10-15 | |||||
| 2018-03-31 | $1.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15 | $3.65K derived: sum of 2 quarters · filed 2019-02-14 | $5.47K 10-Q · filed 2018-05-15 | $7.29K derived: sum of 4 quarters · filed 2019-02-14 | ||||||
| 2017-12-31 | $1.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | $3.65K 10-Q · filed 2019-02-14 | $5.47K derived: sum of 3 quarters · filed 2019-02-14 | $7.29K derived: sum of 4 quarters · filed 2019-02-14 | ||||||
| 2017-09-30 | $1.82K 10-Q · filed 2018-12-14 | $3.65K derived: sum of 2 quarters · filed 2018-12-14 | $5.47K derived: sum of 3 quarters · filed 2018-12-14 | $7.29K derived: sum of 4 quarters · filed 2018-12-14 | ||||||
| 2017-06-30 | $1.82K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | $3.65K derived: sum of 2 quarters · filed 2018-10-15 | $5.47K derived: sum of 3 quarters · filed 2018-10-15 | $7.29K 10-K · filed 2018-10-15 | ||||||
| 2017-03-31 | $1.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15 | $3.65K derived: sum of 2 quarters · filed 2018-05-15 | $5.47K 10-Q · filed 2018-05-15 | $7.29K derived: sum of 4 quarters · filed 2018-05-15 | ||||||
| 2016-12-31 | $1.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $3.65K 10-Q · filed 2018-02-14 | $5.47K derived: sum of 3 quarters · filed 2018-02-14 | $7.29K derived: sum of 4 quarters · filed 2018-02-14 | ||||||
| 2016-09-30 | $1.82K 10-Q · filed 2017-11-14 | $3.65K derived: sum of 2 quarters · filed 2017-11-14 | $5.47K derived: sum of 3 quarters · filed 2017-11-14 | $7.29K derived: sum of 4 quarters · filed 2017-11-14 | ||||||
| 2016-06-30 | $1.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-22 | $3.65K derived: sum of 2 quarters · filed 2017-09-22 | $5.47K derived: sum of 3 quarters · filed 2017-09-22 | $7.29K 10-K · filed 2017-09-22 | ||||||
| 2016-03-31 | $1.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $3.65K derived: sum of 2 quarters · filed 2017-05-15 | $5.47K 10-Q · filed 2017-05-15 | $7.29K derived: sum of 4 quarters · filed 2017-05-15 | ||||||
| 2015-12-31 | $1.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-02 | $3.65K 10-Q · filed 2017-02-02 | $5.47K derived: sum of 3 quarters · filed 2017-02-02 | $7.29K derived: sum of 4 quarters · filed 2017-02-02 | ||||||
| 2015-09-30 | $1.82K 10-Q · filed 2016-11-14 | $3.65K derived: sum of 2 quarters · filed 2016-11-14 | $5.47K derived: sum of 3 quarters · filed 2016-11-14 | $6.78K derived: sum of 4 quarters · filed 2016-11-14 | ||||||
| 2015-06-30 | $1.82K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $3.65K derived: sum of 2 quarters · filed 2016-09-28 | $4.96K derived: sum of 3 quarters · filed 2016-09-28 | $5.25K 10-K · filed 2016-09-28 | ||||||
| 2015-03-31 | $1.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-16 | $3.14K derived: sum of 2 quarters · filed 2016-05-16 | $3.43K 10-Q · filed 2016-05-16 | $4.32K derived: sum of 4 quarters · filed 2016-05-16 | ||||||
| 2014-12-31 | $1.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | $1.61K 10-Q · filed 2016-02-16 | $2.50K derived: sum of 3 quarters · filed 2016-02-16 | $3.38K derived: sum of 4 quarters · filed 2016-02-16 | ||||||
| 2014-09-30 | $295.00 10-Q · filed 2015-11-16 | $1.18K derived: sum of 2 quarters · filed 2015-11-16 | $2.07K derived: sum of 3 quarters · filed 2015-11-16 | $2.95K derived: sum of 4 quarters · filed 2015-11-16 | ||||||
| 2014-06-30 | $886.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | $1.77K derived: sum of 2 quarters · filed 2015-09-28 | $2.66K derived: sum of 3 quarters · filed 2015-09-28 | $3.54K 10-K · filed 2015-09-28 | ||||||
| 2014-03-31 | $886.00 10-Q · filed 2014-05-14 | $1.77K derived: sum of 2 quarters · filed 2014-05-14 | $2.66K 10-Q · filed 2015-05-15 | $2.95K derived: sum of 4 quarters · filed 2014-11-12 | $2.95K 10-Q · filed 2014-05-14 | |||||
| 2013-12-31 | $886.00 10-Q · filed 2014-02-13 | $1.77K 10-Q · filed 2015-02-17 | $2.07K derived: sum of 3 quarters · filed 2014-11-12 | $2.07K derived: sum of 4 quarters · filed 2014-11-12 | $2.07K 10-Q · filed 2014-02-13 | |||||
| 2013-09-30 | $886.00 10-Q · filed 2014-11-12 | $1.18K derived: sum of 2 quarters · filed 2014-11-12 | $1.18K derived: sum of 3 quarters · filed 2014-11-12 | $1.18K derived: sum of 4 quarters · filed 2014-11-12 | $1.18K 10-Q · filed 2013-11-12 | |||||
| 2013-06-30 | $295.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | $295.00 derived: sum of 2 quarters · filed 2014-09-30 | $295.00 derived: sum of 3 quarters · filed 2014-09-30 | $295.00 10-K · filed 2014-09-30 | $295.00 10-K · filed 2013-09-11 | |||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 10-Q · filed 2014-05-14 | |||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-13 | $0.00 10-Q · filed 2014-02-13 | ||||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | |||||||||
| 2012-06-30 | $0.00 10-K · filed 2013-09-11 | |||||||||
| 2011-12-31 | $0.00 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |